Pittsfield pharmacist took Adderall intended for customers, federal prosecutors allege
Federal prosecutors in Massachusetts charged a Pittsfield pharmacist for allegedly stealing Adderall meant for patients. The Department of Justice claims the individual diverted the controlled substance for personal use between late 2022 and early 2024.
Court documents indicate that auditors noticed discrepancies between the pharmacy inventory and the actual pill counts. Officials allege the pharmacist manipulated electronic records to hide the missing medication. These actions triggered a deeper investigation by state and federal regulators into the distribution logs at the facility.
Legal proceedings are moving forward in U.S. District Court. If convicted of the charges involving controlled substance diversion, the defendant faces significant penalties including potential prison time and the loss of pharmacy licensing. The prosecution remains focused on documenting the exact quantity of medication removed from the supply chain.
Patients who used the pharmacy during this timeframe are currently waiting for further guidance from local health authorities. The case highlights ongoing federal efforts to monitor the handling of Schedule II stimulants across private retail locations. Further details will emerge as the evidence moves through the federal discovery process.